Inhibition of recombinant endoplasmic reticulum resident protein 57 (ERp57) increases the protein defolding response and promotes the activation of PERK, which ultimately leads to increased levels of apoptosis in breast cancer cells 27. Here, PDIA3 is linked to breast cancer.